Development and Validation of the MOBI Questionnaire (MOBI)

January 8, 2024 updated by: Hubert Labelle, MD, St. Justine's Hospital

Scoliosis is a common spinal deformity in adolescents. Orthopedic brace treatment is the only conservative (nonsurgical) treatment effective in limiting the progression of this deformity. It is a difficult treatment for young people (discomfort, self-image, limitation in activities) who must wear this rigid orthosis between 20-23 hrs / day during the growth spurt. Recent studies have shown that the effectiveness of this treatment is related to the wearing time of the corset. However, there is a serious problem of compliance to treatment. On average, the brace is worn only 12 hrs / day. A negative perception of the patient with respect to the brace can lead to treatment failure if the brace is not worn. It is therefore essential to understand the impact of the brace on the quality of psychological life, the daily activities and the comfort of young patients. Unfortunately, there is no valid instrument to evaluate all these dimensions. The objective of this project is to develop a questionnaire that can measure the quality of life of patients wearing a brace and validate it for its clinical use.

The investigators have created a questionnaire based on the best knowledge published on the subject, opinions of experts in the field and a group of patient partners.

At the end of this project, a questionnaire will be available for the first time to assess in depth the perception that patients have of their braces. It can be used to adjust braces in the clinic, as well as to support and encourage compliance to the treatment

Study Overview

Status

Recruiting

Intervention / Treatment

Detailed Description

Increase treatment adherence by 50%: 1- by identifying the reasons of non-adherence with MOBI, the first bilingual quality of life (QL) measurement questionnaire dedicated to braces, 2- using for the first time a Multidisciplinary Support Team (MST) for the patient / family.

The BrAIST study showed an inverse correlation between the duration of brace wear and the probability of progression, a wearing time of 0 to 6 hrs / day with a proportion at 59% progression ≥50 ° vs 7% for a brace wear> 17 hours. Knowing that the average daily brace wear duration measured is much lower than that prescribed, there is a problem of compliance whose in which the causes are unknown. Unsuitable questionnaires assessed the QoL of AIS patients on TLSO and have reflected the impact of the disease on psychological health, perceptions of self-image and daily activities, but do not isolate the factors associated with non-compliance to TLSO. In addition, there is no biopsychosocial intervention strategy in care settings to improve compliance.

The investigators have expertise in this field since the investigator have carried out cross-cultural adaptation and validation of 2 QL instruments in the AIS. In addition, the investigator and his team developed a body diagram to evaluate the comfort of patients under brace treatment and correlated with pressure measurements at the skin-brace interface. The investigator's also used in a previous RCT thermal sensors to measure the wearing time of the braces.

The investigator's team propose to develop and validate MOBI (My Orthopedic Brace Inventory), the first bilingual multidimensional QL questionnaire dedicated to the wearing of the brace to measure the physical and functional well-being, emotional and social wellness. We will use MOBI to identify the elements associated with non-compliance to TLSO and for the first time in the world MST, a multi-disciplinary team (nurse, orthotist, psychologist, social worker) to intervene on the 4 identified dimensions, with the assumption that this intervention will improve by 50% the wearing time of the brace.

Study Type

Observational

Enrollment (Estimated)

176

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact Backup

Study Locations

    • Quebec
      • Montréal, Quebec, Canada, H3T 1C5

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

10 years to 16 years (Child)

Accepts Healthy Volunteers

No

Sampling Method

Non-Probability Sample

Study Population

AIS patients with brace treatment.

Description

Inclusion Criteria:

  • AIS.
  • 10-16 years old, with brace treatment.
  • Ability to read and understand English or French.
  • Physical and mental ability to adhere to bracing protocol.

Exclusion Criteria:

  • Diagnosis of other musculoskeletal or developmental illness that might be responsible for the spinal curvature.
  • Patients with symptom of a neurological disorder.
  • Patients with any other disorder of the musculoskeletal system affecting the lower limbs,

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Score distribution for the new MOBI questionnaire scales
Time Frame: At baseline (at recruitment)
To develop a self-report questionnaire to assess the quality of life of scoliotic children treated by a Boston brace. There are 6 sub scales : Emotional well-being (7 items, sub score between 0 and 28, best score is 0); Functional well-being (6 items, subscore between 0 and 24, best score is 0); Physical well-being (4 items, subscore between 0 and 16, best score is 0); Social well-being (6 items, subscore between 0 and 24, best score is 0); Barriers related to Patient (4 items, subscore between 0 and 16, best score is 0); Barriers related to System (3 items, subscore between 0 and 12, best score is 0); Barriers related to Treatment (3 items, subscore between 0 and 12, best score is 0). Total score of the MOBI score is obtained by summing the subscores of all subscales (between 0 and 136, best score is 0).
At baseline (at recruitment)
Internal validity, scale MOBI
Time Frame: At baseline (at recruitment)
Chronbach's alpha coefficient, measured at the first visit and at the second visit.
At baseline (at recruitment)
The test-retest reliability of MOBI questionnaire
Time Frame: At baseline (at recruitment)
The test-retest reliability of MOBI will be evaluated using the intraclass correlation coefficient with about 72 hours interval.
At baseline (at recruitment)
The structural validity of the MOBI questionnaire
Time Frame: At project completion (up to 48 months upon recruitment)
Principal component analysis with factor extraction to identify the factorial structure of the MOBI questionnaire.
At project completion (up to 48 months upon recruitment)

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Hubert Labelle, MD, Ste Justine's

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

February 1, 2019

Primary Completion (Estimated)

December 31, 2025

Study Completion (Estimated)

December 31, 2025

Study Registration Dates

First Submitted

April 2, 2019

First Submitted That Met QC Criteria

April 23, 2019

First Posted (Actual)

April 29, 2019

Study Record Updates

Last Update Posted (Actual)

January 10, 2024

Last Update Submitted That Met QC Criteria

January 8, 2024

Last Verified

January 1, 2024

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

UNDECIDED

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Idiopathic Scoliosis

Clinical Trials on MOBI validation

3
Subscribe